arrow
M

Massimiliano Mirabella

catholic university of the sacred heart
H指数:52
被引数:9,373

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune-mediated necrotizing myopathies: clinico-serological features and treatment outcomes of a large Italian cohort of patients

免疫介导性坏死性肌病:一大规模意大利患者队列的临床血清学特征及治疗结局

2026-08-310
PRE
Dynamics of Myelin-Specific T-Cell Repertoires Mirror Disease Activity and Central Nervous System Trafficking in Multiple Sclerosis

髓鞘特异性T细胞库的动态变化反映多发性硬化症中的疾病活动度和中枢神经系统转运

2026-08-140
OA
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study)

评估接受不同治疗方案序列治疗的视神经脊髓炎患者队列中长期严重不良事件风险的概况:意大利视神经脊髓炎及相关疾病登记研究(I-MS&RD)(ProSA研究)结果

2026-07-040
PRE
Impact of cladribine tablets on PROs in patients with MS: insights from the 1st interim analysis of the CLADFIT-MS study

克立屈滨片对多发性硬化患者结局的影响:来自CLADFIT-MS研究首次中期分析的见解

2026-04-110
OA
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study

真实世界中多发性硬化患者使用克拉屈滨片的经验:一项多中心意大利研究的有效性数据

2025-12-260
OA
Adult Onset of Type 2 Familial Hemophagocytic Lymphohistiocytosis After SARS-CoV-2 Vaccination with an Unusual Neurological Onset: The Great Mimic

成人发病的家族性2型噬血细胞性淋巴组织细胞增多症在SARS-CoV-2疫苗接种后出现,并伴有不典型的神经系统首发症状:伪装大师

2025-11-270
OAAI
Novel missense variants associated with GNE myopathy

与GNE肌病相关的 novel missense variants

2025-10-250
PRE
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty

真实世界中奥法鲁单抗治疗复发型多发性硬化24个月的效果:疗效、安全性及虚弱症的影响

2025-09-190
OAAI
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy

怀孕期间暴露于富马酸二甲酯的多发性硬化症妇女的意大利多中心队列的母婴结局

2024-09-120
PRE
Clinical, Histopathologic, and Genetic Features of Patients With Myofibrillary and Distal Myopathies Experience From the Italian Network
2024-08-271
PRE
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study

Ocrelizumab在阿仑单抗治疗后疾病活动持续存在的MS患者中: 一项多中心意大利研究

2024-08-140
PRE
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience

在MS中使用那他珠单抗治疗的不同方案中的治疗调节剂: 意大利的真实世界经验

2024-04-011
OAAI
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)
2023-10-019
OAAI
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study

在现实环境中评估口服药物对多发性硬化症的治疗反应: 一项MAGNIMS研究

2023-09-296
PRE